The AACE update to its 2026 algorithm for the management of type 2 diabetes includes a new section on diabetes classification.
A University of Virginia Center for Diabetes Technology-developed algorithm—paired with a continuous glucose monitor—can help users better manage their type 2 diabetes by recommending insulin-dose ...
Additional recommendation on the use of obesity medications in diabetes patients is provided in the updated guidelines. The American Diabetes Association ® (ADA) has released its latest evidence-based ...
A University of Virginia Center for Diabetes Technology-developed algorithm – paired with a continuous glucose monitor – can help users better manage ...
SEATTLE — The latest American Association of Clinical Endocrinology (AACE) type 2 diabetes management algorithm uses graphics to focus on individualized care while adding newly compiled information ...
JACKSONVILLE, Fla., May 5, 2023 /PRNewswire/ -- Today, the American Association of Clinical Endocrinology (AACE) announced the publication of the 2023 Comprehensive Type 2 Diabetes Management ...
α-Glucosidase inhibitors 0.5–0.8 Weight neutral Frequent GI side effects, three times/day dosing, expensive Exenatide 0.5–1.0 Weight loss Injections, frequent GI side effects, expensive, little ...
WAN CHAI, WAN CHAI, HONG KONG, January 23, 2026 /EINPresswire.com/ — Even with the advancement of Automated Insulin Delivery (AID) technologies, diabetes management ...
During a session at AdvaMed’s annual MedTech Conference in Boston this fall, when asked which areas of medtech are currently looking most exciting from an R&D perspective, Medtronic CEO Geoff Martha ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results